Clinical Trial Update: The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of three days of intramuscular ziprasidone in patients with psychotic agitation associated with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Geodon (Ziprasidone)

Snippet

Sponsor: Yang Fude | Conditions: Schizophrenia | Phase 4 | Status: UNKNOWN